Myto Therapeutics
Research - Davis, California, United States
Myto Therapeutics Employees
Myto Therapeutics Details
Ixchel Pharma develops novel small-molecules that ameliorate orphan mitochondrial diseases, including Friedreich's ataxia and Leigh Syndrome. Our patented prodrug technology delivers bioactive monomethyl fumarate molecules with superior pharmacokinetics (PK) to other marketed prodrugs. The superior PK of our molecules underlies their greater pharmacodynamic potency to ameliorate mitochondrial diseases. The Mechanism of Action of our IXC-109 suggests it is a 'platform' drug, which could treat multiple mitochondrial diseases.
Website:
http://www.mytothera.com
Employees:
2
HQ:
(530) 304-6810
Location:
Davis, California, United States
Revenue: